85 related articles for article (PubMed ID: 20015301)
1. Bone marrow signal during PET imaging in Hodgkin lymphoma.
Fyfe A; McKay P; Leach M
Br J Haematol; 2010 Apr; 149(2):165. PubMed ID: 20015301
[No Abstract] [Full Text] [Related]
2. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
Molin D; Hagberg H; Suurküla M; Aström G
Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
[No Abstract] [Full Text] [Related]
3. Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma.
Harada S; Shinohara T; Naruse K; Machida H
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27793796
[No Abstract] [Full Text] [Related]
4. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
5. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
6. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of bone marrow involvement by FDG-PET for refractory Hodgkin lymphoma treated by unrelated allogeneic bone marrow transplantation].
Toubai T; Ota S; Onodera M; Baba U; Fujisawa F; Miura Y; Toyoshima N; Tanaka J; Asaka M; Imamura M
Rinsho Ketsueki; 2003 Jul; 44(7):446-50. PubMed ID: 12931562
[TBL] [Abstract][Full Text] [Related]
8. [Bone lymphoma].
Merino Menéndez S; Vega González ML; Blanco Cabellos JA
Sangre (Barc); 1998 Dec; 43(6):521-5. PubMed ID: 10089813
[No Abstract] [Full Text] [Related]
9. Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
Anderlini P; Swanston N; Rashid A; Bueso-Ramos C; Macapinlac HA; Champlin RE
Biol Blood Marrow Transplant; 2008 Apr; 14(4):478-80. PubMed ID: 18342791
[No Abstract] [Full Text] [Related]
10. Malignant lymphoma: bone marrow imaging versus biopsy.
Linden A; Zankovich R; Theissen P; Diehl V; Schicha H
Radiology; 1989 Nov; 173(2):335-9. PubMed ID: 2678249
[TBL] [Abstract][Full Text] [Related]
11. [Picture in Clinical Hematology No. 106].
Rinsho Ketsueki; 2017; 58(8):903. PubMed ID: 28883271
[No Abstract] [Full Text] [Related]
12. Positron emission tomography in patients with Hodgkin's disease: correlation to histopathologic subtypes.
Döbert N; Menzel C; Berner U; Hamscho N; Wördehoff N; Mitrou P; Grünwald F
Cancer Biother Radiopharm; 2003 Aug; 18(4):565-71. PubMed ID: 14503951
[TBL] [Abstract][Full Text] [Related]
13. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
Eyre TA; King AJ; Hatton C; Collins GP
Eur J Haematol; 2014 Jun; 92(6):550-1. PubMed ID: 24483596
[No Abstract] [Full Text] [Related]
14. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
Cheson BD
Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
[TBL] [Abstract][Full Text] [Related]
15. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow and bone scintigraphy in the examination of patients with malignant lymphoma].
Jánoskúti L; Szilvási I; Pápay J; Róna E; Papp G; Benedek S; Fekete S
Orv Hetil; 1988 Oct; 129(42):2247-50. PubMed ID: 3186241
[No Abstract] [Full Text] [Related]
17. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
[TBL] [Abstract][Full Text] [Related]
18. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P; Sica S; Leone G
Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
[TBL] [Abstract][Full Text] [Related]
19. Interim PET in Hodgkin Lymphoma: Is It So Useless?
Meignan M; Cottereau AS; Deau B; Kanoun S; Berriolo-Riedinger A; Casasnovas O
J Nucl Med; 2017 Jul; 58(7):1180. PubMed ID: 28254870
[No Abstract] [Full Text] [Related]
20. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
Hernandez-Maraver D; Hernandez-Navarro F; Gomez-Leon N; Coya J; Rodriguez-Vigil B; Madero R; Pinilla I; Martin-Curto LM
Br J Haematol; 2006 Nov; 135(3):293-302. PubMed ID: 17032175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
